Christelle Retière

11PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedInnate immunityMolecular targetsTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 04, 2025
Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia.

Enora Ferron, Maxime Jullien, Katia Gagne

|Oct 31, 2025
Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity.

Maxime Jullien, Enora Ferron, Catherine Willem

|Jun 22, 2023
Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation.

Nolwenn Legrand, Perla Salameh, Maxime Jullien

|Sep 08, 2021
Activation status dictates the function of unlicensed natural killer cells in mice and humans.

Ethan G Aguilar, Cordelia Dunai, Sean J Judge

|Aug 07, 2021
Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients.

Léa Dubreuil, Patrice Chevallier, Christelle Retière

|Jun 28, 2021
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response.

Dhon Roméo Makanga, Maxime Jullien, Gaëlle David

Pageof 2

Frequent Collaborators

3 joint publications

Marie C Béné

2 joint publications

Thierry Guillaume

2 joint publications

Bercelin Maniangou

2 joint publications

Anne Cesbron